Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Unity Biotechnology completes enrollment in Phase 2 ENVISION study » 08:25
09/19/22
09/19
08:25
09/19/22
08:25
UBX

Unity Biotechnology

/

+

UNITY Biotechnology has…

UNITY Biotechnology has completed enrollment for the ENVISION study, its Phase 2 clinical trial of UBX1325 in patients with wet age-related macular degeneration. This is an active comparator study, examining the efficacy of two doses of UBX1325 compared to every other month treatment with aflibercept through 24 weeks.

ShowHide Related Items >><<
UBX Unity Biotechnology
/

+

UBX Unity Biotechnology
/

+

08/19/22 Wedbush
Unity Biotechnology selloff a buying opportunity, says Wedbush
08/15/22 Citi
Unity Biotechnology price target raised to $8 from $5 at Citi
05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
UBX Unity Biotechnology
/

+

  • 18
    Aug
UBX Unity Biotechnology
/

+

UBX Unity Biotechnology
/

+

Conference/Events
Citigroup to hold a conference » 04:55
09/08/22
09/08
04:55
09/08/22
04:55
ALDX

Aldeyra

$6.44 /

+0.15 (+2.38%)

, AMGN

Amgen

$244.84 /

+2.59 (+1.07%)

, ATAI

Atai Life Sciences

$4.28 /

+0.06 (+1.42%)

, CINC

CinCor Pharma

$29.61 /

-0.225 (-0.75%)

, CLLS

Cellectis

$3.25 /

+0.13 (+4.17%)

, DBTX

Decibel Therapeutics

$5.08 /

+0.42 (+9.01%)

, DNLI

Denali Therapeutics

$29.48 /

+2.34 (+8.62%)

, PLRX

Pliant Therapeutics

$20.11 /

+0.31 (+1.57%)

, PFE

Pfizer

$46.14 /

+0.34 (+0.74%)

, PEAR

Pear Therapeutics

$1.92 /

-0.15 (-7.25%)

, NVS

Novartis

$80.93 /

+1.16 (+1.45%)

, NCNA

NuCana

$1.41 /

+0.05 (+3.68%)

, LLY

Eli Lilly

$311.68 /

+4.94 (+1.61%)

, ROIV

Roivant Sciences

$3.48 /

+0.18 (+5.46%)

, SDGR

Schrodinger

$27.08 /

+1.12 (+4.31%)

, SSTK

Shutterstock

$56.54 /

+1.575 (+2.87%)

, TSVT

2seventy Bio

$14.70 /

+0.78 (+5.60%)

, UBX

Unity Biotechnology

/

+

, ZYME

Zymeworks

$4.73 /

-0.03 (-0.63%)

, RAPT

Rapt Therapeutics

$25.36 /

+2.34 (+10.17%)

, EOLS

Evolus

$10.20 /

+1.2 (+13.33%)

17th Annual BioPharma…

17th Annual BioPharma Conference to be held in Boston on September 7-8.

ShowHide Related Items >><<
ZYME Zymeworks
$4.73 /

-0.03 (-0.63%)

UBX Unity Biotechnology
/

+

TSVT 2seventy Bio
$14.70 /

+0.78 (+5.60%)

SSTK Shutterstock
$56.54 /

+1.575 (+2.87%)

SDGR Schrodinger
$27.08 /

+1.12 (+4.31%)

ROIV Roivant Sciences
$3.48 /

+0.18 (+5.46%)

RAPT Rapt Therapeutics
$25.36 /

+2.34 (+10.17%)

PLRX Pliant Therapeutics
$20.11 /

+0.31 (+1.57%)

PFE Pfizer
$46.14 /

+0.34 (+0.74%)

PEAR Pear Therapeutics
$1.92 /

-0.15 (-7.25%)

NVS Novartis
$80.93 /

+1.16 (+1.45%)

NCNA NuCana
$1.41 /

+0.05 (+3.68%)

LLY Eli Lilly
$311.68 /

+4.94 (+1.61%)

EOLS Evolus
$10.20 /

+1.2 (+13.33%)

DNLI Denali Therapeutics
$29.48 /

+2.34 (+8.62%)

DBTX Decibel Therapeutics
$5.08 /

+0.42 (+9.01%)

CLLS Cellectis
$3.25 /

+0.13 (+4.17%)

CINC CinCor Pharma
$29.61 /

-0.225 (-0.75%)

ATAI Atai Life Sciences
$4.28 /

+0.06 (+1.42%)

AMGN Amgen
$244.84 /

+2.59 (+1.07%)

ALDX Aldeyra
$6.44 /

+0.15 (+2.38%)

ALDX Aldeyra
$6.44 /

+0.15 (+2.38%)

06/09/22 Citi
Aldeyra price target raised to $26 from $21 at Citi
06/08/22 Alliance Global Partners
Alliance Global says Aldeyra trading may be due to regulatory uncertainty
04/27/22 H.C. Wainwright
Aldeyra assumed with a Buy at H.C. Wainwright
04/04/22 JonesTrading
Aldeyra assumed with a Buy at JonesTrading
AMGN Amgen
$244.84 /

+2.59 (+1.07%)

08/08/22 Piper Sandler
Amgen combo data for Lumakras disappoints, says Piper Sandler
08/08/22 JMP Securities
Mirati Therapeutics price target raised to $110 from $90 at JMP Securities
08/05/22 RBC Capital
Amgen price target raised to $236 from $224 at RBC Capital
08/05/22 Piper Sandler
Amgen price target raised to $265 from $260 at Piper Sandler
ATAI Atai Life Sciences
$4.28 /

+0.06 (+1.42%)

09/01/22 Citi
Atai Life Sciences price target lowered to $20 from $22 at Citi
05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
03/31/22 RBC Capital
Atai Life Sciences price target lowered to $9 from $12 at RBC Capital
CINC CinCor Pharma
$29.61 /

-0.225 (-0.75%)

08/21/22 Piper Sandler
CinCor Pharma initiated with an Overweight at Piper Sandler
08/08/22 Oppenheimer
CinCor Pharma price target raised to $60 from $35 at Oppenheimer
07/21/22 Oppenheimer
CinCor Pharma price target raised to $35 from $30 at Oppenheimer
02/01/22 Oppenheimer
CinCor Pharma initiated with an Outperform at Oppenheimer
CLLS Cellectis
$3.25 /

+0.13 (+4.17%)

08/18/22 Citi
Cellectis price target raised to $36 from $34 at Citi
05/18/22 Baird
Cellectis upgraded to Outperform at Baird on valuation 'backstop'
05/18/22 Baird
Cellectis upgraded to Outperform from Neutral at Baird
05/13/22 Barclays
Cellectis price target lowered to $7 from $9 at Barclays
DBTX Decibel Therapeutics
$5.08 /

+0.42 (+9.01%)

05/17/22 Citi
Decibel Therapeutics price target lowered to $15 from $20 at Citi
04/19/22 Baird
Decibel could be next target for Regeneron, says Baird
03/21/22 Barclays
Decibel Therapeutics price target lowered to $7 from $30 at Barclays
12/02/21 JonesTrading
Decibel Therapeutics initiated with a Buy at JonesTrading
DNLI Denali Therapeutics
$29.48 /

+2.34 (+8.62%)

06/23/22 Berenberg
Denali Therapeutics initiated with a Buy at Berenberg
05/06/22 Wedbush
Denali Therapeutics price target lowered to $48 from $62 at Wedbush
12/09/21 Raymond James
Denali Therapeutics assumed with a Market Perform at Raymond James
11/05/21 Evercore ISI
Denali Therapeutics price target raised to $111 from $70 at Evercore ISI
PLRX Pliant Therapeutics
$20.11 /

+0.31 (+1.57%)

09/01/22 Citi
Pliant Therapeutics initiated with a Buy at Citi
08/09/22 H.C. Wainwright
Pliant Therapeutics price target raised to $53 from $45 at H.C. Wainwright
07/26/22 Cantor Fitzgerald
Pliant Therapeutics price target raised to $40 from $36 at Cantor Fitzgerald
07/20/22 SVB Securities
Pliant Therapeutics initiated with an Outperform at SVB Securities
PFE Pfizer
$46.14 /

+0.34 (+0.74%)

09/02/22 Cantor Fitzgerald
Cantor says ACIP recommendations support 'continued tail' for COVID-19 vaccines
08/26/22 Citi
Citi opens 'positive catalyst watches' on GSK, Sanofi after Zantac ruling
08/18/22 Piper Sandler
Biohaven downgraded to Neutral from Overweight at Piper Sandler
08/15/22 RBC Capital
Haleon initiated with a Sector Perform at RBC Capital
PEAR Pear Therapeutics
$1.92 /

-0.15 (-7.25%)

08/12/22 BTIG
Pear Therapeutics price target lowered to $5 from $11 at BTIG
08/12/22 Chardan
Pear Therapeutics price target lowered to $9 from $13 at Chardan
06/24/22 BTIG
Pear Therapeutics price target lowered to $11 from $12 at BTIG
05/24/22 Cowen
Pear Therapeutics revenues raised on strong Rx growth, says Cowen
NVS Novartis
$80.93 /

+1.16 (+1.45%)

09/07/22 Morgan Stanley
Novartis price target lowered to CHF 88 from CHF 97 at Morgan Stanley
09/07/22 Kepler Cheuvreux
Novartis upgraded to Buy from Hold at Kepler Cheuvreux
08/05/22 Truist
Global Blood could complement any oncology franchise, says Truist
08/04/22 Truist
Truist sees Novartis, Vertex as logical suitors for Global Blood
NCNA NuCana
$1.41 /

+0.05 (+3.68%)

04/13/22 Truist
NuCana price target lowered to $6 from $22 at Truist
03/03/22 Cowen
NuCana downgraded to Market Perform at Cowen after trial failure
03/03/22 Cowen
NuCana downgraded to Market Perform from Outperform at Cowen
11/24/21 H.C. Wainwright
NuCana price target lowered to $9 from $10 at H.C. Wainwright
LLY Eli Lilly
$311.68 /

+4.94 (+1.61%)

09/06/22 Morgan Stanley
Biogen named a 'Catalyst Driven Idea' at Morgan Stanley
09/06/22 BMO Capital
Eli Lilly price target raised to $396 from $369 at BMO Capital
08/30/22 Piper Sandler
Altimmune management confident on NAFLD Phase 1b study, says Piper Sandler
08/25/22 Citi
Eli Lilly price target raised to $370 from $285 at Citi
ROIV Roivant Sciences
$3.48 /

+0.18 (+5.46%)

08/16/22 Citi
Roivant Sciences price target raised to $10 from $9 at Citi
05/23/22 SVB Securities
Roivant Sciences initiated with an Outperform at SVB Leerink
04/29/22 Cantor Fitzgerald
Roivant Sciences initiated with an Overweight at Cantor Fitzgerald
12/15/21 Goldman Sachs
Roivant Sciences initiated with a Buy at Goldman Sachs
SDGR Schrodinger
$27.08 /

+1.12 (+4.31%)

07/26/22 Piper Sandler
Schrodinger price target raised to $86 from $84 at Piper Sandler
06/28/22 Piper Sandler
Piper says Schrodinger has 'potentially best-in-class' MALT1 inhibitor in '1505
04/12/22 Piper Sandler
Schrodinger has 'potent and highly selective' molecule , says Piper Sandler
02/28/22 Citi
Schrodinger initiated with a Buy at Citi
SSTK Shutterstock
$56.54 /

+1.575 (+2.87%)

08/25/22 Redburn
Redburn starts Shutterstock with Buy, Getty Images with Neutral
08/25/22 Redburn
Shutterstock initiated with a Buy at Redburn
07/28/22 Morgan Stanley
Shutterstock initiated with an Equal Weight at Morgan Stanley
07/27/22 Truist
Shutterstock price target lowered to $100 from $120 at Truist
TSVT 2seventy Bio
$14.70 /

+0.78 (+5.60%)

08/12/22 Canaccord
2seventy Bio price target lowered to $28 from $42 at Canaccord
07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
05/02/22 Goldman Sachs
2seventy Bio initiated with a Buy at Goldman Sachs
02/10/22 SVB Securities
SVB Leerink bullish on 2seventy Bio, initiates with an Outperform
UBX Unity Biotechnology
/

+

08/19/22 Wedbush
Unity Biotechnology selloff a buying opportunity, says Wedbush
08/15/22 Citi
Unity Biotechnology price target raised to $8 from $5 at Citi
05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
ZYME Zymeworks
$4.73 /

-0.03 (-0.63%)

08/29/22 Citi
Zymeworks price target lowered to $27 from $28 at Citi
05/23/22 H.C. Wainwright
Zymeworks price target lowered to $40 from $44 at H.C. Wainwright
05/09/22 Citi
Zymeworks should reject 'opportunistic' $10.50 per share offer, says Citi
05/05/22 Guggenheim
Zymeworks upgraded to Buy at Guggenheim amid low expectations
RAPT Rapt Therapeutics
$25.36 /

+2.34 (+10.17%)

05/24/22 Cantor Fitzgerald
Rapt Therapeutics assumed with an Overweight at Cantor Fitzgerald
05/12/22 Piper Sandler
Rapt Therapeutics price target lowered to $30 from $52 at Piper Sandler
12/09/21 JPMorgan
Rapt Therapeutics initiated with an Overweight at JPMorgan
11/16/21 Cantor Fitzgerald
Rapt Therapeutics price target lowered to $58 from $71 at Cantor Fitzgerald
EOLS Evolus
$10.20 /

+1.2 (+13.33%)

06/23/22 Needham
Needham starts 'aesthetics emerging star' Evolus at Buy
06/23/22 Needham
Evolus initiated with a Buy at Needham
05/12/22 Barclays
Evolus upgraded to Equal Weight from Underweight at Barclays
04/28/22 Barclays
Evolus price target raised to $8 from $7 at Barclays
ZYME Zymeworks
$4.73 /

-0.03 (-0.63%)

UBX Unity Biotechnology
/

+

TSVT 2seventy Bio
$14.70 /

+0.78 (+5.60%)

SSTK Shutterstock
$56.54 /

+1.575 (+2.87%)

SDGR Schrodinger
$27.08 /

+1.12 (+4.31%)

ROIV Roivant Sciences
$3.48 /

+0.18 (+5.46%)

RAPT Rapt Therapeutics
$25.36 /

+2.34 (+10.17%)

PLRX Pliant Therapeutics
$20.11 /

+0.31 (+1.57%)

PFE Pfizer
$46.14 /

+0.34 (+0.74%)

PEAR Pear Therapeutics
$1.92 /

-0.15 (-7.25%)

NVS Novartis
$80.93 /

+1.16 (+1.45%)

NCNA NuCana
$1.41 /

+0.05 (+3.68%)

LLY Eli Lilly
$311.68 /

+4.94 (+1.61%)

EOLS Evolus
$10.20 /

+1.2 (+13.33%)

DNLI Denali Therapeutics
$29.48 /

+2.34 (+8.62%)

CLLS Cellectis
$3.25 /

+0.13 (+4.17%)

CINC CinCor Pharma
$29.61 /

-0.225 (-0.75%)

ATAI Atai Life Sciences
$4.28 /

+0.06 (+1.42%)

AMGN Amgen
$244.84 /

+2.59 (+1.07%)

ALDX Aldeyra
$6.44 /

+0.15 (+2.38%)

  • 18
    Aug
  • 11
    Aug
  • 13
    Jul
  • 27
    Jan
  • 07
    Jan
PFE Pfizer
$46.14 /

+0.34 (+0.74%)

NVS Novartis
$80.93 /

+1.16 (+1.45%)

LLY Eli Lilly
$311.68 /

+4.94 (+1.61%)

AMGN Amgen
$244.84 /

+2.59 (+1.07%)

ZYME Zymeworks
$4.73 /

-0.03 (-0.63%)

UBX Unity Biotechnology
/

+

TSVT 2seventy Bio
$14.70 /

+0.78 (+5.60%)

SSTK Shutterstock
$56.54 /

+1.575 (+2.87%)

ROIV Roivant Sciences
$3.48 /

+0.18 (+5.46%)

PLRX Pliant Therapeutics
$20.11 /

+0.31 (+1.57%)

PFE Pfizer
$46.14 /

+0.34 (+0.74%)

PEAR Pear Therapeutics
$1.92 /

-0.15 (-7.25%)

NVS Novartis
$80.93 /

+1.16 (+1.45%)

LLY Eli Lilly
$311.68 /

+4.94 (+1.61%)

DBTX Decibel Therapeutics
$5.08 /

+0.42 (+9.01%)

CINC CinCor Pharma
$29.61 /

-0.225 (-0.75%)

ATAI Atai Life Sciences
$4.28 /

+0.06 (+1.42%)

AMGN Amgen
$244.84 /

+2.59 (+1.07%)

ALDX Aldeyra
$6.44 /

+0.15 (+2.38%)

UBX Unity Biotechnology
/

+

TSVT 2seventy Bio
$14.70 /

+0.78 (+5.60%)

PLRX Pliant Therapeutics
$20.11 /

+0.31 (+1.57%)

PFE Pfizer
$46.14 /

+0.34 (+0.74%)

PEAR Pear Therapeutics
$1.92 /

-0.15 (-7.25%)

NVS Novartis
$80.93 /

+1.16 (+1.45%)

LLY Eli Lilly
$311.68 /

+4.94 (+1.61%)

CINC CinCor Pharma
$29.61 /

-0.225 (-0.75%)

AMGN Amgen
$244.84 /

+2.59 (+1.07%)

Conference/Events
Citigroup to hold a conference » 16:05
09/07/22
09/07
16:05
09/07/22
16:05
ALDX

Aldeyra

$6.44 /

+0.145 (+2.31%)

, AMGN

Amgen

$244.97 /

+2.72 (+1.12%)

, ATAI

Atai Life Sciences

$4.30 /

+0.08 (+1.90%)

, CINC

CinCor Pharma

$29.46 /

-0.37 (-1.24%)

, CLLS

Cellectis

$3.24 /

+0.12 (+3.85%)

, DBTX

Decibel Therapeutics

$5.13 /

+0.47 (+10.09%)

, DNLI

Denali Therapeutics

$29.43 /

+2.29 (+8.44%)

, PLRX

Pliant Therapeutics

$20.13 /

+0.33 (+1.67%)

, PFE

Pfizer

$46.20 /

+0.4 (+0.87%)

, PEAR

Pear Therapeutics

$1.91 /

-0.16 (-7.73%)

, NVS

Novartis

$80.95 /

+1.18 (+1.48%)

, NCNA

NuCana

$1.39 /

+0.025 (+1.84%)

, LLY

Eli Lilly

$312.32 /

+5.58 (+1.82%)

, ROIV

Roivant Sciences

$3.51 /

+0.21 (+6.37%)

, SDGR

Schrodinger

$27.20 /

+1.24 (+4.78%)

, SSTK

Shutterstock

$56.46 /

+1.5 (+2.73%)

, TSVT

2seventy Bio

$14.57 /

+0.65 (+4.67%)

, UBX

Unity Biotechnology

/

+

, ZYME

Zymeworks

$4.65 /

-0.105 (-2.21%)

, RAPT

Rapt Therapeutics

$25.28 /

+2.26 (+9.82%)

, EOLS

Evolus

$10.22 /

+1.22 (+13.56%)

17th Annual BioPharma…

17th Annual BioPharma Conference to be held in Boston on September 7-8.

ShowHide Related Items >><<
ZYME Zymeworks
$4.65 /

-0.105 (-2.21%)

UBX Unity Biotechnology
/

+

TSVT 2seventy Bio
$14.57 /

+0.65 (+4.67%)

SSTK Shutterstock
$56.46 /

+1.5 (+2.73%)

SDGR Schrodinger
$27.20 /

+1.24 (+4.78%)

ROIV Roivant Sciences
$3.51 /

+0.21 (+6.37%)

RAPT Rapt Therapeutics
$25.28 /

+2.26 (+9.82%)

PLRX Pliant Therapeutics
$20.13 /

+0.33 (+1.67%)

PFE Pfizer
$46.20 /

+0.4 (+0.87%)

PEAR Pear Therapeutics
$1.91 /

-0.16 (-7.73%)

NVS Novartis
$80.95 /

+1.18 (+1.48%)

NCNA NuCana
$1.39 /

+0.025 (+1.84%)

LLY Eli Lilly
$312.32 /

+5.58 (+1.82%)

EOLS Evolus
$10.22 /

+1.22 (+13.56%)

DNLI Denali Therapeutics
$29.43 /

+2.29 (+8.44%)

DBTX Decibel Therapeutics
$5.13 /

+0.47 (+10.09%)

CLLS Cellectis
$3.24 /

+0.12 (+3.85%)

CINC CinCor Pharma
$29.46 /

-0.37 (-1.24%)

ATAI Atai Life Sciences
$4.30 /

+0.08 (+1.90%)

AMGN Amgen
$244.97 /

+2.72 (+1.12%)

ALDX Aldeyra
$6.44 /

+0.145 (+2.31%)

ALDX Aldeyra
$6.44 /

+0.145 (+2.31%)

06/09/22 Citi
Aldeyra price target raised to $26 from $21 at Citi
06/08/22 Alliance Global Partners
Alliance Global says Aldeyra trading may be due to regulatory uncertainty
04/27/22 H.C. Wainwright
Aldeyra assumed with a Buy at H.C. Wainwright
04/04/22 JonesTrading
Aldeyra assumed with a Buy at JonesTrading
AMGN Amgen
$244.97 /

+2.72 (+1.12%)

08/08/22 Piper Sandler
Amgen combo data for Lumakras disappoints, says Piper Sandler
08/08/22 JMP Securities
Mirati Therapeutics price target raised to $110 from $90 at JMP Securities
08/05/22 RBC Capital
Amgen price target raised to $236 from $224 at RBC Capital
08/05/22 Piper Sandler
Amgen price target raised to $265 from $260 at Piper Sandler
ATAI Atai Life Sciences
$4.30 /

+0.08 (+1.90%)

09/01/22 Citi
Atai Life Sciences price target lowered to $20 from $22 at Citi
05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
03/31/22 RBC Capital
Atai Life Sciences price target lowered to $9 from $12 at RBC Capital
CINC CinCor Pharma
$29.46 /

-0.37 (-1.24%)

08/21/22 Piper Sandler
CinCor Pharma initiated with an Overweight at Piper Sandler
08/08/22 Oppenheimer
CinCor Pharma price target raised to $60 from $35 at Oppenheimer
07/21/22 Oppenheimer
CinCor Pharma price target raised to $35 from $30 at Oppenheimer
02/01/22 Oppenheimer
CinCor Pharma initiated with an Outperform at Oppenheimer
CLLS Cellectis
$3.24 /

+0.12 (+3.85%)

08/18/22 Citi
Cellectis price target raised to $36 from $34 at Citi
05/18/22 Baird
Cellectis upgraded to Outperform at Baird on valuation 'backstop'
05/18/22 Baird
Cellectis upgraded to Outperform from Neutral at Baird
05/13/22 Barclays
Cellectis price target lowered to $7 from $9 at Barclays
DBTX Decibel Therapeutics
$5.13 /

+0.47 (+10.09%)

05/17/22 Citi
Decibel Therapeutics price target lowered to $15 from $20 at Citi
04/19/22 Baird
Decibel could be next target for Regeneron, says Baird
03/21/22 Barclays
Decibel Therapeutics price target lowered to $7 from $30 at Barclays
12/02/21 JonesTrading
Decibel Therapeutics initiated with a Buy at JonesTrading
DNLI Denali Therapeutics
$29.43 /

+2.29 (+8.44%)

06/23/22 Berenberg
Denali Therapeutics initiated with a Buy at Berenberg
05/06/22 Wedbush
Denali Therapeutics price target lowered to $48 from $62 at Wedbush
12/09/21 Raymond James
Denali Therapeutics assumed with a Market Perform at Raymond James
11/05/21 Evercore ISI
Denali Therapeutics price target raised to $111 from $70 at Evercore ISI
PLRX Pliant Therapeutics
$20.13 /

+0.33 (+1.67%)

09/01/22 Citi
Pliant Therapeutics initiated with a Buy at Citi
08/09/22 H.C. Wainwright
Pliant Therapeutics price target raised to $53 from $45 at H.C. Wainwright
07/26/22 Cantor Fitzgerald
Pliant Therapeutics price target raised to $40 from $36 at Cantor Fitzgerald
07/20/22 SVB Securities
Pliant Therapeutics initiated with an Outperform at SVB Securities
PFE Pfizer
$46.20 /

+0.4 (+0.87%)

09/02/22 Cantor Fitzgerald
Cantor says ACIP recommendations support 'continued tail' for COVID-19 vaccines
08/26/22 Citi
Citi opens 'positive catalyst watches' on GSK, Sanofi after Zantac ruling
08/18/22 Piper Sandler
Biohaven downgraded to Neutral from Overweight at Piper Sandler
08/15/22 RBC Capital
Haleon initiated with a Sector Perform at RBC Capital
PEAR Pear Therapeutics
$1.91 /

-0.16 (-7.73%)

08/12/22 BTIG
Pear Therapeutics price target lowered to $5 from $11 at BTIG
08/12/22 Chardan
Pear Therapeutics price target lowered to $9 from $13 at Chardan
06/24/22 BTIG
Pear Therapeutics price target lowered to $11 from $12 at BTIG
05/24/22 Cowen
Pear Therapeutics revenues raised on strong Rx growth, says Cowen
NVS Novartis
$80.95 /

+1.18 (+1.48%)

09/07/22 Morgan Stanley
Novartis price target lowered to CHF 88 from CHF 97 at Morgan Stanley
09/07/22 Kepler Cheuvreux
Novartis upgraded to Buy from Hold at Kepler Cheuvreux
08/05/22 Truist
Global Blood could complement any oncology franchise, says Truist
08/04/22 Truist
Truist sees Novartis, Vertex as logical suitors for Global Blood
NCNA NuCana
$1.39 /

+0.025 (+1.84%)

04/13/22 Truist
NuCana price target lowered to $6 from $22 at Truist
03/03/22 Cowen
NuCana downgraded to Market Perform at Cowen after trial failure
03/03/22 Cowen
NuCana downgraded to Market Perform from Outperform at Cowen
11/24/21 H.C. Wainwright
NuCana price target lowered to $9 from $10 at H.C. Wainwright
LLY Eli Lilly
$312.32 /

+5.58 (+1.82%)

09/06/22 Morgan Stanley
Biogen named a 'Catalyst Driven Idea' at Morgan Stanley
09/06/22 BMO Capital
Eli Lilly price target raised to $396 from $369 at BMO Capital
08/30/22 Piper Sandler
Altimmune management confident on NAFLD Phase 1b study, says Piper Sandler
08/25/22 Citi
Eli Lilly price target raised to $370 from $285 at Citi
ROIV Roivant Sciences
$3.51 /

+0.21 (+6.37%)

08/16/22 Citi
Roivant Sciences price target raised to $10 from $9 at Citi
05/23/22 SVB Securities
Roivant Sciences initiated with an Outperform at SVB Leerink
04/29/22 Cantor Fitzgerald
Roivant Sciences initiated with an Overweight at Cantor Fitzgerald
12/15/21 Goldman Sachs
Roivant Sciences initiated with a Buy at Goldman Sachs
SDGR Schrodinger
$27.20 /

+1.24 (+4.78%)

07/26/22 Piper Sandler
Schrodinger price target raised to $86 from $84 at Piper Sandler
06/28/22 Piper Sandler
Piper says Schrodinger has 'potentially best-in-class' MALT1 inhibitor in '1505
04/12/22 Piper Sandler
Schrodinger has 'potent and highly selective' molecule , says Piper Sandler
02/28/22 Citi
Schrodinger initiated with a Buy at Citi
SSTK Shutterstock
$56.46 /

+1.5 (+2.73%)

08/25/22 Redburn
Redburn starts Shutterstock with Buy, Getty Images with Neutral
08/25/22 Redburn
Shutterstock initiated with a Buy at Redburn
07/28/22 Morgan Stanley
Shutterstock initiated with an Equal Weight at Morgan Stanley
07/27/22 Truist
Shutterstock price target lowered to $100 from $120 at Truist
TSVT 2seventy Bio
$14.57 /

+0.65 (+4.67%)

08/12/22 Canaccord
2seventy Bio price target lowered to $28 from $42 at Canaccord
07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
05/02/22 Goldman Sachs
2seventy Bio initiated with a Buy at Goldman Sachs
02/10/22 SVB Securities
SVB Leerink bullish on 2seventy Bio, initiates with an Outperform
UBX Unity Biotechnology
/

+

08/19/22 Wedbush
Unity Biotechnology selloff a buying opportunity, says Wedbush
08/15/22 Citi
Unity Biotechnology price target raised to $8 from $5 at Citi
05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
ZYME Zymeworks
$4.65 /

-0.105 (-2.21%)

08/29/22 Citi
Zymeworks price target lowered to $27 from $28 at Citi
05/23/22 H.C. Wainwright
Zymeworks price target lowered to $40 from $44 at H.C. Wainwright
05/09/22 Citi
Zymeworks should reject 'opportunistic' $10.50 per share offer, says Citi
05/05/22 Guggenheim
Zymeworks upgraded to Buy at Guggenheim amid low expectations
RAPT Rapt Therapeutics
$25.28 /

+2.26 (+9.82%)

05/24/22 Cantor Fitzgerald
Rapt Therapeutics assumed with an Overweight at Cantor Fitzgerald
05/12/22 Piper Sandler
Rapt Therapeutics price target lowered to $30 from $52 at Piper Sandler
12/09/21 JPMorgan
Rapt Therapeutics initiated with an Overweight at JPMorgan
11/16/21 Cantor Fitzgerald
Rapt Therapeutics price target lowered to $58 from $71 at Cantor Fitzgerald
EOLS Evolus
$10.22 /

+1.22 (+13.56%)

06/23/22 Needham
Needham starts 'aesthetics emerging star' Evolus at Buy
06/23/22 Needham
Evolus initiated with a Buy at Needham
05/12/22 Barclays
Evolus upgraded to Equal Weight from Underweight at Barclays
04/28/22 Barclays
Evolus price target raised to $8 from $7 at Barclays
ZYME Zymeworks
$4.65 /

-0.105 (-2.21%)

UBX Unity Biotechnology
/

+

TSVT 2seventy Bio
$14.57 /

+0.65 (+4.67%)

SSTK Shutterstock
$56.46 /

+1.5 (+2.73%)

SDGR Schrodinger
$27.20 /

+1.24 (+4.78%)

ROIV Roivant Sciences
$3.51 /

+0.21 (+6.37%)

RAPT Rapt Therapeutics
$25.28 /

+2.26 (+9.82%)

PLRX Pliant Therapeutics
$20.13 /

+0.33 (+1.67%)

PFE Pfizer
$46.20 /

+0.4 (+0.87%)

PEAR Pear Therapeutics
$1.91 /

-0.16 (-7.73%)

NVS Novartis
$80.95 /

+1.18 (+1.48%)

NCNA NuCana
$1.39 /

+0.025 (+1.84%)

LLY Eli Lilly
$312.32 /

+5.58 (+1.82%)

EOLS Evolus
$10.22 /

+1.22 (+13.56%)

DNLI Denali Therapeutics
$29.43 /

+2.29 (+8.44%)

CLLS Cellectis
$3.24 /

+0.12 (+3.85%)

CINC CinCor Pharma
$29.46 /

-0.37 (-1.24%)

ATAI Atai Life Sciences
$4.30 /

+0.08 (+1.90%)

AMGN Amgen
$244.97 /

+2.72 (+1.12%)

ALDX Aldeyra
$6.44 /

+0.145 (+2.31%)

  • 18
    Aug
  • 11
    Aug
  • 13
    Jul
  • 27
    Jan
  • 07
    Jan
PFE Pfizer
$46.20 /

+0.4 (+0.87%)

NVS Novartis
$80.95 /

+1.18 (+1.48%)

LLY Eli Lilly
$312.32 /

+5.58 (+1.82%)

AMGN Amgen
$244.97 /

+2.72 (+1.12%)

ZYME Zymeworks
$4.65 /

-0.105 (-2.21%)

UBX Unity Biotechnology
/

+

TSVT 2seventy Bio
$14.57 /

+0.65 (+4.67%)

SSTK Shutterstock
$56.46 /

+1.5 (+2.73%)

ROIV Roivant Sciences
$3.51 /

+0.21 (+6.37%)

PLRX Pliant Therapeutics
$20.13 /

+0.33 (+1.67%)

PFE Pfizer
$46.20 /

+0.4 (+0.87%)

PEAR Pear Therapeutics
$1.91 /

-0.16 (-7.73%)

NVS Novartis
$80.95 /

+1.18 (+1.48%)

LLY Eli Lilly
$312.32 /

+5.58 (+1.82%)

DBTX Decibel Therapeutics
$5.13 /

+0.47 (+10.09%)

CINC CinCor Pharma
$29.46 /

-0.37 (-1.24%)

ATAI Atai Life Sciences
$4.30 /

+0.08 (+1.90%)

AMGN Amgen
$244.97 /

+2.72 (+1.12%)

ALDX Aldeyra
$6.44 /

+0.145 (+2.31%)

UBX Unity Biotechnology
/

+

TSVT 2seventy Bio
$14.57 /

+0.65 (+4.67%)

PLRX Pliant Therapeutics
$20.13 /

+0.33 (+1.67%)

PFE Pfizer
$46.20 /

+0.4 (+0.87%)

PEAR Pear Therapeutics
$1.91 /

-0.16 (-7.73%)

NVS Novartis
$80.95 /

+1.18 (+1.48%)

LLY Eli Lilly
$312.32 /

+5.58 (+1.82%)

CINC CinCor Pharma
$29.46 /

-0.37 (-1.24%)

AMGN Amgen
$244.97 /

+2.72 (+1.12%)

Over a month ago
Options
Largest borrow rate increases among liquid names » 08:45
08/19/22
08/19
08:45
08/19/22
08:45
NRGV

Energy Vault

$5.59 /

+0.285 (+5.38%)

, LFLY

Leafly

$2.00 /

+0.03 (+1.52%)

, KGC

Kinross Gold

$3.49 /

+0.11 (+3.25%)

, YUMC

Yum China

$46.90 /

-1.29 (-2.68%)

, BRCC

BRC Inc.

$10.19 /

+0.265 (+2.67%)

, CGC

Canopy Growth

$3.80 /

-0.265 (-6.52%)

, UBX

Unity Biotechnology

/

+

, DNMR

Danimer Scientific

$5.20 /

+0.07 (+1.36%)

, AMRS

Amyris

$3.55 /

-0.13 (-3.54%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Energy Vault Holdings (NRGV) 62.88% +4.91, Leafly Holdings (LFLY) 51.81% +1.80, Kinross Gold (KGC) 9.19% +0.87, Yum China (YUMC) 1.67% +0.56, iShares MSCI China (MCHI) 2.92% +0.52, SilverBox Engaged Merger Corp (BRCC) 109.42% +0.34, Canopy Growth (CGC) 5.52% +0.31, Unity Biotechnology (UBX) 7.24% +0.26, Danimer Scientific (DNMR) 24.33% +0.26, and Amyris (AMRS) 4.27% +0.17.

ShowHide Related Items >><<
YUMC Yum China
$46.90 /

-1.29 (-2.68%)

UBX Unity Biotechnology
/

+

NRGV Energy Vault
$5.59 /

+0.285 (+5.38%)

LFLY Leafly
$2.00 /

+0.03 (+1.52%)

KGC Kinross Gold
$3.49 /

+0.11 (+3.25%)

DNMR Danimer Scientific
$5.20 /

+0.07 (+1.36%)

CGC Canopy Growth
$3.80 /

-0.265 (-6.52%)

BRCC BRC Inc.
$10.19 /

+0.265 (+2.67%)

AMRS Amyris
$3.55 /

-0.13 (-3.54%)

NRGV Energy Vault
$5.59 /

+0.285 (+5.38%)

08/09/22 Cowen
Energy Vault price target lowered to $11.50 from $18 at Cowen
06/29/22 Chardan
Energy Vault initiated with a Buy at Chardan
03/22/22 Guggenheim
Guggenheim starts Energy Vault at Buy, sees plans as 'ambitious but plausible'
03/21/22 Guggenheim
Energy Vault initiated with a Buy at Guggenheim
LFLY Leafly
$2.00 /

+0.03 (+1.52%)

08/12/22 Oppenheimer
Oppenheimer says Leafly valuation 'beginning to look attractive'
08/12/22 Cowen
Leafly price target lowered to $4 from $12 at Cowen
08/12/22 Benchmark
Leafly price target lowered to $6.50 from $12.00 at Benchmark
05/20/22 Cowen
Cowen starts Leafly with Outperform with its early mover advantage
KGC Kinross Gold
$3.49 /

+0.11 (+3.25%)

08/03/22 National Bank
Kinross Gold price target lowered to C$8.25 from C$9.25 at National Bank
07/21/22 National Bank
Kinross Gold price target lowered to C$9.25 from C$13 at National Bank
07/20/22 Stifel
Kinross Gold price target lowered to C$10 from C$11 at Stifel
07/19/22 Barclays
Kinross Gold price target lowered to $6 from $7 at Barclays
YUMC Yum China
$46.90 /

-1.29 (-2.68%)

07/26/22
Yum China upgraded to Buy from Hold at CMB International
01/24/22 OTR Global
Yum China downgraded to Mixed from Positive at OTR Global
12/31/21 Morgan Stanley
Yum China price target lowered to $70 from $74 at Morgan Stanley
09/20/21 Stifel
Starbucks price target trimmed to $130 at Stifel after Yum China disclosures
BRCC BRC Inc.
$10.19 /

+0.265 (+2.67%)

08/12/22 Truist
BRC Inc. price target lowered to $12 from $15 at Truist
08/01/22 Citi
BRC Inc. transferred with Neutral, $10 target at Citi
07/11/22 Citi
BRC Inc. price target lowered to $10 from $13 at Citi
05/26/22 Tigress Financial
BRC Inc. initiated with a Buy at Tigress Financial
CGC Canopy Growth
$3.80 /

-0.265 (-6.52%)

08/08/22 Canaccord
Canopy Growth price target lowered to C$2.75 from C$3.50 at Canaccord
08/08/22 Piper Sandler
Canopy Growth price target lowered to $2.50 from $3 at Piper Sandler
07/01/22 Canaccord
Canopy Growth price target lowered to C$3.50 from C$4.50 at Canaccord
07/01/22 Canaccord
Canopy Growth price target lowered to C$3.50 from C$4.50 at Canaccord
UBX Unity Biotechnology
/

+

08/19/22 Wedbush
Unity Biotechnology selloff a buying opportunity, says Wedbush
08/15/22 Citi
Unity Biotechnology price target raised to $8 from $5 at Citi
05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
DNMR Danimer Scientific
$5.20 /

+0.07 (+1.36%)

11/16/21 Jefferies
Danimer Scientific price target lowered to $30 from $34 at Jefferies
09/23/21 Cowen
Danimer Scientific initiated with an Outperform at Cowen
09/23/21 Cowen
Danimer Scientific initiated with an Outperform at Cowen
AMRS Amyris
$3.55 /

-0.13 (-3.54%)

08/10/22 Roth Capital
Roth Capital downgrades Amyris to Neutral, lowers price target to $2
08/10/22 Roth Capital
Amyris downgraded to Neutral from Buy at Roth Capital
06/24/22 JPMorgan
Amyris initiated with a Neutral at JPMorgan
05/25/22 Piper Sandler
Amyris initiated with a Neutral at Piper Sandler
YUMC Yum China
$46.90 /

-1.29 (-2.68%)

UBX Unity Biotechnology
/

+

NRGV Energy Vault
$5.59 /

+0.285 (+5.38%)

LFLY Leafly
$2.00 /

+0.03 (+1.52%)

KGC Kinross Gold
$3.49 /

+0.11 (+3.25%)

DNMR Danimer Scientific
$5.20 /

+0.07 (+1.36%)

CGC Canopy Growth
$3.80 /

-0.265 (-6.52%)

BRCC BRC Inc.
$10.19 /

+0.265 (+2.67%)

AMRS Amyris
$3.55 /

-0.13 (-3.54%)

  • 18
    Aug
YUMC Yum China
$46.90 /

-1.29 (-2.68%)

NRGV Energy Vault
$5.59 /

+0.285 (+5.38%)

KGC Kinross Gold
$3.49 /

+0.11 (+3.25%)

CGC Canopy Growth
$3.80 /

-0.265 (-6.52%)

YUMC Yum China
$46.90 /

-1.29 (-2.68%)

UBX Unity Biotechnology
/

+

NRGV Energy Vault
$5.59 /

+0.285 (+5.38%)

LFLY Leafly
$2.00 /

+0.03 (+1.52%)

KGC Kinross Gold
$3.49 /

+0.11 (+3.25%)

CGC Canopy Growth
$3.80 /

-0.265 (-6.52%)

BRCC BRC Inc.
$10.19 /

+0.265 (+2.67%)

AMRS Amyris
$3.55 /

-0.13 (-3.54%)

YUMC Yum China
$46.90 /

-1.29 (-2.68%)

NRGV Energy Vault
$5.59 /

+0.285 (+5.38%)

LFLY Leafly
$2.00 /

+0.03 (+1.52%)

KGC Kinross Gold
$3.49 /

+0.11 (+3.25%)

DNMR Danimer Scientific
$5.20 /

+0.07 (+1.36%)

CGC Canopy Growth
$3.80 /

-0.265 (-6.52%)

BRCC BRC Inc.
$10.19 /

+0.265 (+2.67%)

AMRS Amyris
$3.55 /

-0.13 (-3.54%)

Recommendations
Unity Biotechnology selloff a buying opportunity, says Wedbush » 07:22
08/19/22
08/19
07:22
08/19/22
07:22
UBX

Unity Biotechnology

/

+

Wedbush analyst Andreas…

Wedbush analyst Andreas Argyrides says Unity Biotechnology's cash overhang is lifted with greater than one year of cash following its follow-on offering. Its pro forma cash of $107M gets Unity to "key value-driving readouts over the next 12-months," Argyrides tells investors in a research note. The analyst views the recent weakness in the stock as unwarranted and sees a "buying opportunity into upcoming catalysts." Argyrides keeps an Outperform rating on Unity Biotechnology with a $4 price target.

ShowHide Related Items >><<
UBX Unity Biotechnology
/

+

UBX Unity Biotechnology
/

+

08/15/22 Citi
Unity Biotechnology price target raised to $8 from $5 at Citi
05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy from Neutral at Roth Capital
UBX Unity Biotechnology
/

+

  • 18
    Aug
UBX Unity Biotechnology
/

+

Syndicate
Unity Biotechnology 64.3M share Secondary priced at $.70 » 05:52
08/18/22
08/18
05:52
08/18/22
05:52
UBX

Unity Biotechnology

/

+

The deal size was…

The deal size was increased to $45M in common stock from $25M in common stock. SVB Securities, Cantor Fitzgerald and Mizuho acted as joint book running managers for the offering.

ShowHide Related Items >><<
UBX Unity Biotechnology
/

+

UBX Unity Biotechnology
/

+

08/15/22 Citi
Unity Biotechnology price target raised to $8 from $5 at Citi
05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy from Neutral at Roth Capital
UBX Unity Biotechnology
/

+

  • 18
    Aug
UBX Unity Biotechnology
/

+

On The Fly
Fly Intel: After-Hours Movers » 18:34
08/16/22
08/16
18:34
08/16/22
18:34
A

Agilent

$132.76 /

-1.18 (-0.88%)

, BBBY

Bed Bath & Beyond

$20.74 /

+4.745 (+29.67%)

, SAVA

Cassava Sciences

$20.19 /

-0.02 (-0.10%)

, QTRX

Quanterix

$9.74 /

-0.42 (-4.13%)

, SWX

Southwest Gas

$80.04 /

+1.31 (+1.66%)

, PAVM

PAVmed

$1.99 /

-0.29 (-12.75%)

, QBTS

D-Wave Quantum

$10.43 /

-0.17 (-1.60%)

, JKHY

Jack Henry

$210.87 /

+0.34 (+0.16%)

, LVLU

Lulu's Fashion Lounge

$7.84 /

+0.49 (+6.67%)

, ASLE

AerSale

$19.92 /

-0.245 (-1.22%)

, UBX

Unity Biotechnology

$1.37 /

+0.095 (+7.48%)

, LMPX

LMP Automotive

$8.44 /

+0.49 (+6.16%)

, OSH

Oak Street Health

$27.28 /

-1.445 (-5.03%)

Check out this evening's…

ShowHide Related Items >><<
UBX Unity Biotechnology
$1.37 /

+0.095 (+7.48%)

SWX Southwest Gas
$80.04 /

+1.31 (+1.66%)

SAVA Cassava Sciences
$20.19 /

-0.02 (-0.10%)

QTRX Quanterix
$9.74 /

-0.42 (-4.13%)

QBTS D-Wave Quantum
$10.43 /

-0.17 (-1.60%)

PAVM PAVmed
$1.99 /

-0.29 (-12.75%)

OSH Oak Street Health
$27.28 /

-1.445 (-5.03%)

LMPX LMP Automotive
$8.44 /

+0.49 (+6.16%)

JKHY Jack Henry
$210.87 /

+0.34 (+0.16%)

BBBY Bed Bath & Beyond
$20.74 /

+4.745 (+29.67%)

A Agilent
$132.76 /

-1.18 (-0.88%)

A Agilent
$132.76 /

-1.18 (-0.88%)

07/20/22 UBS
Agilent initiated with a Buy at UBS
07/08/22 Citi
Agilent downgraded to Neutral from Buy at Citi
06/03/22 Cowen
Agilent premium valuation remains warranted, says Cowen
06/02/22 KeyBanc
Agilent price target lowered to $155 from $195 at KeyBanc
BBBY Bed Bath & Beyond
$20.74 /

+4.745 (+29.67%)

08/16/22 Odeon Capital
Odeon Capital downgrades Bed Bath & Beyond to Sell with $7.50 price target
08/16/22 Odeon Capital
Bed Bath & Beyond downgraded to Sell from Hold at Odeon Capital
08/16/22 B. Riley
B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell
08/16/22 B. Riley
Bed Bath & Beyond downgraded to Sell from Neutral at B. Riley
SAVA Cassava Sciences
$20.19 /

-0.02 (-0.10%)

08/11/22 B. Riley
Cassava Sciences price target lowered to $44 from $58 at B. Riley
06/02/22 Univest Securities
Univest keeps Sell on Cassava after medical journal retracts article
05/06/22 Univest Securities
Univest says Cassava enrollment still 'severely lags' others in Alzheimer's
05/06/22 B. Riley
Cassava Sciences price target lowered to $58 from $72 at B. Riley
QTRX Quanterix
$9.74 /

-0.42 (-4.13%)

08/15/22 Canaccord
Quanterix downgraded to Hold from Buy at Canaccord
08/09/22 Cowen
Quanterix downgraded to Market Perform from Outperform at Cowen
08/09/22 SVB Securities
Quanterix downgraded to Market Perform from Outperform at SVB Securities
05/11/22 Cowen
Quanterix price target lowered to $38 from $60 at Cowen
SWX Southwest Gas
$80.04 /

+1.31 (+1.66%)

08/10/22 Wells Fargo
Southwest Gas price target lowered to $86 from $101 at Wells Fargo
08/04/22 BofA
Southwest Gas share reaction to strategic review update 'overdone,' says BofA
06/09/22 Argus
Southwest Gas upgraded to Buy from Hold at Argus
05/10/22 Wells Fargo
Southwest Gas price target raised to $101 from $84 at Wells Fargo
PAVM PAVmed
$1.99 /

-0.29 (-12.75%)

04/07/22 Maxim
PAVmed price target lowered to $4 from $10 at Maxim
02/10/22 Cantor Fitzgerald
PAVmed assumed with an Overweight at Cantor Fitzgerald
QBTS D-Wave Quantum
$10.43 /

-0.17 (-1.60%)

07/27/22 Craig-Hallum
Craig-Hallum bullish on D-Wave Quantum, initiates SPAC DPCM Capital with a Buy
07/08/22 Benchmark
DPCM Capital initiated with a Buy at Benchmark
JKHY Jack Henry
$210.87 /

+0.34 (+0.16%)

07/25/22 Oppenheimer
Jack Henry price target lowered to $214 from $220 at Oppenheimer
06/15/22 Morgan Stanley
Jack Henry initiated with an Equal Weight at Morgan Stanley
03/01/22 Oppenheimer
Jack Henry upgraded to Outperform from Perform at Oppenheimer
02/11/22 DA Davidson
Jack Henry price target raised to $204 from $188 at DA Davidson
LVLU Lulu's Fashion Lounge
$7.84 /

+0.49 (+6.67%)

07/29/22 Cowen
Lulu's Fashion Lounge price target lowered to $12 from $22 at Cowen
07/29/22 Baird
Lulu's Fashion Lounge price target lowered to $10 from $17 at Baird
07/22/22 Piper Sandler
Lulu's Fashion Lounge downgraded to Neutral from Overweight at Piper Sandler
07/21/22 KeyBanc
KeyBanc transitions coverage of Global Brands & E-Commerce with cautious view
ASLE AerSale
$19.92 /

-0.245 (-1.22%)

UBX Unity Biotechnology
$1.37 /

+0.095 (+7.48%)

08/15/22 Citi
Unity Biotechnology price target raised to $8 from $5 at Citi
05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy from Neutral at Roth Capital
LMPX LMP Automotive
$8.44 /

+0.49 (+6.16%)

OSH Oak Street Health
$27.28 /

-1.445 (-5.03%)

08/08/22 Barclays
Oak Street Health price target raised to $34 from $31 at Barclays
07/27/22 Stifel
Oak Street Health price target raised to $35 from $25 at Stifel
07/21/22 Stifel
Logical to see Oak Street, Cano as 'in play' after 1Life deal, says Stifel
07/11/22 Evercore ISI
Evercore downgrades 1Life Healthcare to In Line on valuation after jump
UBX Unity Biotechnology
$1.37 /

+0.095 (+7.48%)

SWX Southwest Gas
$80.04 /

+1.31 (+1.66%)

SAVA Cassava Sciences
$20.19 /

-0.02 (-0.10%)

QTRX Quanterix
$9.74 /

-0.42 (-4.13%)

QBTS D-Wave Quantum
$10.43 /

-0.17 (-1.60%)

PAVM PAVmed
$1.99 /

-0.29 (-12.75%)

OSH Oak Street Health
$27.28 /

-1.445 (-5.03%)

LVLU Lulu's Fashion Lounge
$7.84 /

+0.49 (+6.67%)

LMPX LMP Automotive
$8.44 /

+0.49 (+6.16%)

JKHY Jack Henry
$210.87 /

+0.34 (+0.16%)

BBBY Bed Bath & Beyond
$20.74 /

+4.745 (+29.67%)

ASLE AerSale
$19.92 /

-0.245 (-1.22%)

A Agilent
$132.76 /

-1.18 (-0.88%)

  • 17
    Aug
  • 18
    Aug
  • 17
    Aug
  • 29
    Mar
  • 11
    Nov
SWX Southwest Gas
$80.04 /

+1.31 (+1.66%)

SAVA Cassava Sciences
$20.19 /

-0.02 (-0.10%)

BBBY Bed Bath & Beyond
$20.74 /

+4.745 (+29.67%)

UBX Unity Biotechnology
$1.37 /

+0.095 (+7.48%)

SWX Southwest Gas
$80.04 /

+1.31 (+1.66%)

SAVA Cassava Sciences
$20.19 /

-0.02 (-0.10%)

QTRX Quanterix
$9.74 /

-0.42 (-4.13%)

OSH Oak Street Health
$27.28 /

-1.445 (-5.03%)

LVLU Lulu's Fashion Lounge
$7.84 /

+0.49 (+6.67%)

JKHY Jack Henry
$210.87 /

+0.34 (+0.16%)

BBBY Bed Bath & Beyond
$20.74 /

+4.745 (+29.67%)

A Agilent
$132.76 /

-1.18 (-0.88%)

SAVA Cassava Sciences
$20.19 /

-0.02 (-0.10%)

QBTS D-Wave Quantum
$10.43 /

-0.17 (-1.60%)

OSH Oak Street Health
$27.28 /

-1.445 (-5.03%)

LVLU Lulu's Fashion Lounge
$7.84 /

+0.49 (+6.67%)

BBBY Bed Bath & Beyond
$20.74 /

+4.745 (+29.67%)

A Agilent
$132.76 /

-1.18 (-0.88%)

Syndicate
Unity Biotechnology files to sell $25M in common stock » 16:02
08/16/22
08/16
16:02
08/16/22
16:02
UBX

Unity Biotechnology

$1.36 /

+0.09 (+7.09%)

SVB Securities, Cantor…

SVB Securities, Cantor and Mizuho Securities are acting as joint book-running managers for the proposed offering. Wedbush PacGrow is acting as lead manager for the proposed offering.

ShowHide Related Items >><<
UBX Unity Biotechnology
$1.36 /

+0.09 (+7.09%)

UBX Unity Biotechnology
$1.36 /

+0.09 (+7.09%)

08/15/22 Citi
Unity Biotechnology price target raised to $8 from $5 at Citi
05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy from Neutral at Roth Capital
UBX Unity Biotechnology
$1.36 /

+0.09 (+7.09%)

UBX Unity Biotechnology
$1.36 /

+0.09 (+7.09%)

Recommendations
Unity Biotechnology price target raised to $8 from $5 at Citi » 06:59
08/15/22
08/15
06:59
08/15/22
06:59
UBX

Unity Biotechnology

$1.28 /

+0.43 (+50.59%)

Citi analyst Yigal…

Citi analyst Yigal Nochomovitz raised the firm's price target on Unity Biotechnology to $8 from $5 and keeps a Buy rating on the shares. While acknowledging he was cautious heading into the Phase 2 BEHOLD interim readout for UBX1325 in DME, Nochomovitz said the data were "better than expected" and he is raising his view on the odds of success for DME to 35% from about 15% with early proof-of-concept achieved.

ShowHide Related Items >><<
UBX Unity Biotechnology
$1.28 /

+0.43 (+50.59%)

UBX Unity Biotechnology
$1.28 /

+0.43 (+50.59%)

05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy from Neutral at Roth Capital
12/15/21 Wedbush
Wedbush bullish on Unity Biotechnology, initiates with an Outperform
UBX Unity Biotechnology
$1.28 /

+0.43 (+50.59%)

UBX Unity Biotechnology
$1.28 /

+0.43 (+50.59%)

On The Fly
Fly Intel: Pre-market Movers » 08:59
08/12/22
08/12
08:59
08/12/22
08:59
UBX

Unity Biotechnology

$0.85 /

-0.1199 (-12.36%)

, APLT

Applied Therapeutics

$1.31 /

+0.09 (+7.38%)

, RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

, AIRS

AirSculpt Technologies

$8.85 /

-0.45 (-4.84%)

, PAYO

Payoneer Global

$5.68 /

+0.045 (+0.80%)

, TOST

Toast

$18.12 /

-0.33 (-1.79%)

, RIVN

Rivian Automotive

$38.91 /

+1.475 (+3.94%)

, LPTX

Leap Therapeutics

$1.32 /

+0.15 (+12.82%)

, PLXP

PLx Pharma

$2.59 /

+0.015 (+0.58%)

, SPB

Spectrum Brands

$70.37 /

+0.75 (+1.08%)

, CODX

Co-Diagnostics

$6.44 /

-0.195 (-2.94%)

, ILMN

Illumina

$227.64 /

+0.44 (+0.19%)

, LAW

CS Disco

$28.96 /

+0.39 (+1.37%)

, ELF

e.l.f. Beauty

$36.44 /

-0.02 (-0.05%)

Check out this morning's…

ShowHide Related Items >><<
UBX Unity Biotechnology
$0.85 /

-0.1199 (-12.36%)

TOST Toast
$18.12 /

-0.33 (-1.79%)

SPB Spectrum Brands
$70.37 /

+0.75 (+1.08%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

PLXP PLx Pharma
$2.59 /

+0.015 (+0.58%)

PAYO Payoneer Global
$5.68 /

+0.045 (+0.80%)

LPTX Leap Therapeutics
$1.32 /

+0.15 (+12.82%)

LAW CS Disco
$28.96 /

+0.39 (+1.37%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ELF e.l.f. Beauty
$36.44 /

-0.02 (-0.05%)

CODX Co-Diagnostics
$6.44 /

-0.195 (-2.94%)

APLT Applied Therapeutics
$1.31 /

+0.09 (+7.38%)

AIRS AirSculpt Technologies
$8.85 /

-0.45 (-4.84%)

UBX Unity Biotechnology
$0.85 /

-0.1199 (-12.36%)

05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy from Neutral at Roth Capital
12/15/21 Wedbush
Wedbush bullish on Unity Biotechnology, initiates with an Outperform
APLT Applied Therapeutics
$1.31 /

+0.09 (+7.38%)

04/13/22 Truist
Applied Therapeutics price target lowered to $6 from $85 at Truist
03/21/22 Barclays
Applied Therapeutics price target lowered to $2.50 from $7 at Barclays
01/05/22 Citi
Applied Therapeutics price target lowered to $30 from $38 at Citi
01/04/22 Goldman Sachs
Applied Therapeutics price target lowered to $3 from $10 at Goldman Sachs
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
AIRS AirSculpt Technologies
$8.85 /

-0.45 (-4.84%)

06/16/22 Morgan Stanley
AirSculpt downgraded to Equal Weight from Overweight at Morgan Stanley
02/09/22 Piper Sandler
Piper Sandler bullish into AirSculpt Technologies Q4 results
01/25/22 Piper Sandler
AirSculpt Technologies transferred with Overweight at Piper Sandler
12/21/21 Piper Sandler
AirSculpt should could double from current levels, says Piper Sandler
PAYO Payoneer Global
$5.68 /

+0.045 (+0.80%)

07/14/22 Goldman Sachs
Payoneer Global upgraded to Buy from Neutral at Goldman Sachs
05/13/22 Northland
Payoneer Global price target lowered to $9 from $14 at Northland
05/13/22 Citi
Payoneer Global price target raised to $7.50 from $6.50 at Citi
03/04/22 Needham
Payoneer Global price target lowered to $7 from $13 at Needham
TOST Toast
$18.12 /

-0.33 (-1.79%)

08/12/22 Needham
Toast price target raised to $27 from $21 at Needham
08/12/22 KeyBanc
Toast price target raised to $25 from $18 at KeyBanc
05/17/22 Mizuho
Toast price target lowered to $18 from $19 at Mizuho
05/13/22 Needham
Toast price target lowered to $21 from $38 at Needham
RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

08/12/22 DA Davidson
Rivian Automotive price target raised to $27 from $24 at DA Davidson
08/12/22 Morgan Stanley
Rivian Automotive's liqudity can last through most of FY23, says Morgan Stanley
08/12/22 Mizuho
Rivian Automotive price target lowered to $65 from $70 at Mizuho
07/18/22 Deutsche Bank
Rivian Automotive price target lowered to $46 from $69 at Deutsche Bank
LPTX Leap Therapeutics
$1.32 /

+0.15 (+12.82%)

06/06/22 Piper Sandler
Piper says Leap's DKN-01 combo showed 'interesting early signal of activity'
05/27/22 Piper Sandler
Leap Therapeutics price target lowered to $4 from $6 at Piper Sandler
01/23/22 Piper Sandler
Piper ups Leap Therapeutics target to $6 following DKN-01's ASCO GI Update
12/30/21 Mizuho
Mizuho announces top oncology stock picks for 2022
PLXP PLx Pharma
$2.59 /

+0.015 (+0.58%)

03/15/22 BWS Financial
BWS drops coverage of PLx Pharma, says off Amazon again
12/07/21 Raymond James
Raymond James upgrades PLx Pharma on 'compelling entry point'
12/07/21 Raymond James
PLx Pharma upgraded to Outperform from Market Perform at Raymond James
11/12/21 JMP Securities
PLx Pharma reported strong quarter for Vazalore, says JMP Securities
SPB Spectrum Brands
$70.37 /

+0.75 (+1.08%)

07/18/22 Oppenheimer
Spectrum Brands price target lowered to $95 from $125 at Oppenheimer
07/18/22 UBS
Spectrum Brands price target lowered to $109 from $119 at UBS
07/18/22 Wells Fargo
Spectrum Brands price target lowered to $100 from $122 at Wells Fargo
07/13/22 Raymond James
Spectrum Brands initiated with a Market Perform at Raymond James
CODX Co-Diagnostics
$6.44 /

-0.195 (-2.94%)

08/12/22 Sidoti
Co-Diagnostics downgraded to Neutral from Buy at Sidoti
05/16/22 H.C. Wainwright
Co-Diagnostics price target lowered to $12 from $15 at H.C. Wainwright
12/29/21 Sidoti
Sidoti starts Co-Diagnostics at Buy, sees opportunities opened by COVID-19 test
12/29/21 Sidoti
Co-Diagnostics initiated with a Buy at Sidoti
ILMN Illumina
$227.64 /

+0.44 (+0.19%)

08/12/22 Piper Sandler
Piper a buyer of Illumina weakness ahead of Genomics Forum
08/12/22 Canaccord
Illumina price target lowered to $380 from $450 at Canaccord
08/12/22 Stifel
Illumina price target lowered to $300 from $480 at Stifel
08/12/22 Citi
Illumina price target lowered to $200 from $220 at Citi
LAW CS Disco
$28.96 /

+0.39 (+1.37%)

08/12/22 Canaccord
CS Disco downgraded to Hold at Canaccord as estimates get reset
08/12/22 Stifel
CS Disco price target lowered to $30 from $40 at Stifel
08/12/22 BofA
CS Disco downgraded to Neutral from Buy at BofA
08/12/22 Canaccord
CS Disco downgraded to Hold from Buy at Canaccord
ELF e.l.f. Beauty
$36.44 /

-0.02 (-0.05%)

08/12/22 Cowen
e.l.f. Beauty downgraded to Market Perform at Cowen on valuation
08/12/22 Cowen
e.l.f. Beauty downgraded to Market Perform from Outperform at Cowen
08/04/22 Truist
e.l.f. Beauty price target raised to $40 from $35 at Truist
07/21/22 JPMorgan
e.l.f. Beauty price target raised to $35 from $30 at JPMorgan
UBX Unity Biotechnology
$0.85 /

-0.1199 (-12.36%)

TOST Toast
$18.12 /

-0.33 (-1.79%)

SPB Spectrum Brands
$70.37 /

+0.75 (+1.08%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

PLXP PLx Pharma
$2.59 /

+0.015 (+0.58%)

PAYO Payoneer Global
$5.68 /

+0.045 (+0.80%)

LPTX Leap Therapeutics
$1.32 /

+0.15 (+12.82%)

LAW CS Disco
$28.96 /

+0.39 (+1.37%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ELF e.l.f. Beauty
$36.44 /

-0.02 (-0.05%)

CODX Co-Diagnostics
$6.44 /

-0.195 (-2.94%)

APLT Applied Therapeutics
$1.31 /

+0.09 (+7.38%)

AIRS AirSculpt Technologies
$8.85 /

-0.45 (-4.84%)

  • 23
    Jun
  • 10
    Nov
  • 29
    Oct
  • 22
    Sep
  • 22
    Sep
  • 15
    Sep
RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

PAYO Payoneer Global
$5.68 /

+0.045 (+0.80%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ELF e.l.f. Beauty
$36.44 /

-0.02 (-0.05%)

CODX Co-Diagnostics
$6.44 /

-0.195 (-2.94%)

APLT Applied Therapeutics
$1.31 /

+0.09 (+7.38%)

AIRS AirSculpt Technologies
$8.85 /

-0.45 (-4.84%)

TOST Toast
$18.12 /

-0.33 (-1.79%)

RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

PAYO Payoneer Global
$5.68 /

+0.045 (+0.80%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

CODX Co-Diagnostics
$6.44 /

-0.195 (-2.94%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.